Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) 347.3496.47-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 347.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025347.34
Mar202496.47
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2025 347.34
260.05
Mar2024 96.47
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹50.4 Cr -6.2% -27.2% -54% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,116.0 Cr -4.7% -13.7% -24.5% Stock Analytics
KIRI INDUSTRIES ₹2,194.1 Cr -7.1% -19.8% -41.9% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,392.2 Cr 0.3% -9.7% -41.1% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹934.2 Cr -7.3% -13.8% -6.1% Stock Analytics
BODAL CHEMICALS ₹692.6 Cr 16.8% 14.1% -11.4% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-6.2%

-27.2%

-54%

SENSEX

-2.6%

-10.2%

-1.6%


You may also like the below Video Courses